STOCK TITAN

If You Invested in Carmell Corporation Warrant (CTCXW)

Surgical & Medical Instruments & Apparatus · NASDAQ
See the CTCXW overview
CTCXW has not traded since Mar 7, 2025. Its last close was $0.0267, so every figure on this page ends there and the 1, 5 and 10 year results count back from that close.
$1,000 invested 1 Year Before Its Last Close
N/A
Comparable prices start Oct 16, 2024
$1,000 invested 5 Years Before Its Last Close
N/A
Comparable prices start Oct 16, 2024
$1,000 invested 10 Years Before Its Last Close
N/A
Comparable prices start Oct 16, 2024

What $1,000 or $10,000 in CTCXW Was Worth at Its Last Close

Real historical value by amount invested and how long before the last close
If you invested 1 year before 5 years before 10 years before Since Oct 16, 2024
$1,000 — — — $267 -73%
$10,000 — — — $2,670 -73%

Based on real historical closing prices adjusted for stock splits, without dividends, through the latest market close. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results. We start CTCXW on Oct 16, 2024 because the prices we hold from before that date cannot be compared with the later ones, and a return measured across the two would be wrong.

Custom Calculation

Choose your own date and amount for CTCXW

$1,000 Investment Over Time

CTCXW vs S&P 500

Year-by-Year Returns

CTCXW annual performance
Year Start Price End Price Annual Return Cumulative
2024Oct 16, 2024 to Dec 24, 2024 $0.10 $0.04 -60.0% -60.0%
2025Dec 24, 2024 to Mar 7, 2025 $0.04 $0.0267 -33.3% -73.3%

About Carmell Corporation Warrant

NASDAQ

CTCXW represents the publicly traded redeemable warrants that were originally issued in connection with Carmell Corporation, a company described as a bio-aesthetics business. According to a corporate announcement, Carmell Corporation has undertaken a rebranding and name change to Longevity Health Holdings, Inc., with its common stock and redeemable warrants beginning to trade under new symbols.

The company announcement states that Carmell Corporation, identified by the symbols CTCX and CTCXW on Nasdaq, changed its corporate name to Longevity Health Holdings, Inc.. In the same announcement, it is noted that the company’s common stock and redeemable warrants began trading under the symbols XAGE and XAGEW, respectively, at the open of trading on March 10, 2025. This means that CTCXW functions as a historical ticker for the warrants associated with the entity that is now known as Longevity Health Holdings, Inc.

The company is described in the announcement as a bio-aesthetics company with a business focus on longevity and healthy aging. The communication explains that the new corporate name is intended to reflect this focus on longevity and healthy aging and to align the market and investor-facing identity with its business direction and growth strategy. It also mentions that the company’s strategy includes growth through acquisitions and strategic partnerships in addition to organic growth of its existing business.

The announcement refers to the company’s allogeneic PRP Secretome technology, which it characterizes as a scientific advancement in regenerative bio-aesthetics. It also notes that the company completed an acquisition of Elevai Skincare, Inc., which brought in a commercial product pipeline based on stem cell exosome technology. The announcement further indicates that branding for existing marketed products remained unchanged following the rebranding.

Because CTCXW is a historical symbol tied to Carmell Corporation prior to the rebranding to Longevity Health Holdings, Inc., investors and researchers using this page are typically looking for background on the warrants that were associated with the former Carmell identity and for context on how those warrants relate to the company now trading under the XAGE and XAGEW symbols.

Business focus and strategic direction

In the rebranding announcement, the company’s leadership states that the new name Longevity Health Holdings, Inc. reflects a business focus that includes bio-aesthetics and a broader emphasis on longevity and healthy aging. The statement also mentions possible future expansion into segments such as diagnostics and nutrition, and describes a growth strategy that involves acquisitions and strategic partnerships along with the development of existing operations.

The company highlights two technology-related elements in the same communication: its allogeneic PRP Secretome technology for regenerative bio-aesthetics and the stem cell exosome technology associated with Elevai Skincare, Inc. These references indicate that the company links its bio-aesthetics and longevity positioning to these underlying scientific and technological approaches.

Historical context for CTCXW

CTCXW is identified in the announcement as the symbol for the company’s redeemable warrants when the corporate name was Carmell Corporation. The same document explains that, as part of the rebranding, those redeemable warrants began trading under the symbol XAGEW on March 10, 2025. As a result, CTCXW should be understood as a former warrant symbol that is now associated historically with Carmell Corporation prior to its transition to Longevity Health Holdings, Inc.

Users researching CTCXW may be interested in understanding that the warrants originally tied to Carmell Corporation are now referenced under XAGEW following the rebranding. The announcement does not provide additional structural details about the warrants themselves but does make clear the relationship between the old and new symbols.

Industry classification

The sector information provided for this page associates the company with the Surgical & Medical Instruments & Apparatus sector. The company’s own announcement, however, describes it as a bio-aesthetics company with a focus on longevity and healthy aging. Together, these references position the historical CTCXW warrants within the context of a business that connects medical or bio-aesthetic technologies with applications in appearance and aging.

Last Close
$0.0267
View full CTCXW overview

Frequently Asked Questions

Carmell Corporation Warrant investment returns

How much was $1,000 invested in Carmell Corporation Warrant worth at its last close?

Limited historical data is available for CTCXW. The prices we can compare start on 2024-10-16.

Has Carmell Corporation Warrant outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare CTCXW performance over available time periods.

For informational and educational purposes only, not investment advice.